Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Project Updates and Milestones news
(page 14)
1 May 2026
Perpetual Next selects JPB Logistics for Delfzijl biomethanol storage
MoU to negotiate storage/handling for a 220,000 t/y biomethanol plant; planned tank capacity 21,000–35,000 m³; logistics via inbound pipeline, outbound barge, trucks as backup; final on FID.
1 May 2026
Novo Nordisk launches Ozempic pill — FDA‑approved oral semaglutide for adults with type 2 diabetes
Tablets (1.5, 4, 9 mg) debut in US May 4. Reformulated from Rybelsus, available at 70,000+ pharmacies; insurance from $25; self-pay $149/199/299/month. Approved to reduce cardiovascular events
1 May 2026
LyondellBasell sells select European polymers assets to AEQUITA
Sale of select European olefins and polyolefins sites in Berre, Münchsmünster, Carrington and Tarragona closes; APS stays in Tarragona. Divested unit renamed Velogy to sharpen portfolio and capital
30 April 2026
Messer 2025 sustainability report — 2% GHG reduction
Year‑on‑year 2% reduction in market‑based GHGs from operations; renewable electricity and solar installs; ZeCarb carbon services; independent limited assurance for materiality and select KPIs.
30 April 2026
Sinopec launches Fenghuo industrial AI agent
Introduces 'Fenghuo' industrial AI agent: a production-capable digital colleague that analyzes data, runs engineering simulations, invokes toolchains, and executes long multi-step tasks autonomously.
30 April 2026
MOL to acquire O&GD upstream assets in Hungary
Buys 51% stakes in three Central Hungary concessions (~0.7 mboepd) plus Eastern Hungary assets (~0.2 mboepd), adding ~0.9 mboepd to group production; closing Q3 2026, subject to approvals.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
30 April 2026
Uniper receives preliminary approval for hydrogen-ready CCGT Unit 8 at Staudinger
Regional authority grants preliminary approval for hydrogen-ready 890 MW CCGT; feasibility, emissions and habitat issues resolved; first partial permit due Q3 2026; project to enter capacity auctions
30 April 2026
FUCHS SE completes acquisition of OPET FUCHS JV
Completed takeover of Turkish JV, gaining full ownership of Istanbul-based entity and Aliaga (Izmir) plant. New MD Ahmet Oral from May 1. ~250 staff; ~€100M projected revenue.
30 April 2026
Avantium completes titanium weld repairs at FDCA flagship plant
Weld repairs completed with engineering partners. Commissioning continues: utilities and sugar dehydration online; oxidation and purification in final start-up. Commercial sales expected H2 2026
30 April 2026
Petrobras posts 1Q26 own production record of 3.23 MMboed
Ramp-up of multiple FPSOs and 10 new wells drove production gains (3.7% QoQ, 16.1% YoY); operated production 4.65 MMboed. Refining utilization, S10 diesel output and logistics records; LPG imports fell.
30 April 2026
Petrobras resumes urea production at Ansa in Araucária, PR
Urea output resumed after 2020 hibernation following R$870M reactivation; mobilization created 2,000 jobs and ~700 ongoing; restart after ARLA‑32 and ammonia tests strengthens domestic supply
30 April 2026
Symrise expands Food & Beverage capabilities in Barcelona
Upgraded site adds powdered production and large-scale mixer, modern application and quality labs for faster prototyping, smoother scale-up, local technical support, and solar/water reuse.
30 April 2026
Umicore Q1 momentum points to ~€1bn adjusted EBITDA in 2026
Strong Q1: Catalysis and Recycling strong; Specialty led by cobalt; CAM volumes modest, take‑or‑pay compensation; anode JV in place; capex up; leverage <2x
30 April 2026
OMV Petrom Q1 2026 Results
Strong asset output; Clean CCS EBIT 1.5bn lei (+16%); net income 1bn lei (-4%); CAPEX 1.6bn lei (+14%); state contributions 4.1bn lei (+9%); E&P down, production -3.1%; refining margin and power output rose
30 April 2026
Borouge Q1 2026: $156M Net Profit on Operational Resilience
Q1 revenue $1.2B; production 1.21Mt (98% capacity), sales 1.09Mt. 61% of March output rerouted via alternative logistics. Prices rose 62% in March. H2 2025 dividend $658M; merger forms global polyolefins platform.
30 April 2026
Roche to present ophthalmology portfolio data at ARVO 2026
ARVO 2026: real‑world data show Vabysmo reduces retinal fluid in nAMD/DME; Susvimo enables sustained delivery with lower treatment burden; early vamikibart IL‑6 results; 45+ abstracts.
30 April 2026
PETRONAS, ENEOS Xplora: ENEOS to re-enter MLNG Tiga with 10% stake
Reaffirmed long-term partnership strengthens energy security and steady LNG supply to Asia, notably Japan; underscores asset resilience and investor confidence in Malaysia’s LNG sector.
30 April 2026
Technip Energies Q1 2026 Results
>€6bn orders, backlog >€20bn; revenue €1.8bn, EBITDA €149m, FCF €132m (89% conv). Middle East disruptions defer €500–600m; Project Delivery guidance cut to €5.7–6.3bn; TP&S steady.
30 April 2026
Moody’s Affirms ORLEN A3 Rating
Moody's notes strong liquidity and baa2 BCA with stable outlook. Solid balance sheet and cash flows can fund capex and dividends. Diverse supply, flexible trading and 2026 projects boost resilience.
30 April 2026
Eli Lilly Q1 2026: Revenue up 56%, raises full‑year guidance
EPS jumped ~170% reported (~156% non‑GAAP); volume growth offset lower realized prices; FDA approved oral GLP‑1 Foundayo; positive Phase‑3 readouts; four acquisitions announced
30 April 2026
Merck & Co Q1 2026 Results — Sales Growth, Regulatory Approvals and Clinical Milestones
Q1 revenue $16.3B; KEYTRUDA $8.0B. GAAP loss $1.72/sh, non-GAAP loss $1.28/sh after $9.0B Cidara charge. Announced Terns acquisition; raised 2026 sales to $65.8-67.0B and non-GAAP EPS $5.04-5.16
30 April 2026
OMV: Clean CCS operating result ~EUR 1.0bn in Q1 2026
Q1: operating cash flow €776m (€1,624m excl NWC, +20%); net income €323m; leverage 17%. Energy down, Fuels flat, Chemicals up on Borealis reclass. and higher polyolefin margins; Borouge closed
30 April 2026
TotalEnergies and Nextnorth begin construction of 440 MW solar plant in Philippines
Financial close; construction begun on 440 MWp solar in Ilagan, Isabela. Online end‑2027. Produces 13.5 TWh/20 yrs; >50% sold via long‑term C&I contracts, remainder to grid via govt auction. $300M
29 April 2026
Genentech to present ophthalmology data at ARVO 2026
ARVO presentations: real-world Vabysmo data show retinal drying in wet AMD/DME; Susvimo demonstrates sustained delivery and reduced treatment burden; vamikibart shows early efficacy; >45 abstracts
29 April 2026
SABIC Q1 2026 results
Q1: adjusted EBITDA +25% to SAR4.15bn; revenue -6% to SAR26.15bn; adjusted net income SAR816m; realized $220m recurring EBITDA savings; divestments announced; urea capacity could rise 54%
29 April 2026
Novo Nordisk: Denecimig (Mim8) reduces annualised bleeding rate in haemophilia A regardless of inhibitor status
Denecimig (Mim8) cut annualised bleeding rates in haemophilia A (with/without inhibitors) in Phase 3 FRONTIER2 for once-monthly/weekly dosing; well tolerated, no thromboembolic events
29 April 2026
Evonik opens PEEK magnet‑wire lab in China
China lab develops PEEK rectangular magnet-wire for NEV motors: extrusion/coating, dimensional checks and reliability tests (BDV, PDIV, corona, oil-aging) to accelerate product development.
29 April 2026
GSK Q1 2026 — Specialty Medicines Drive Growth
Q1 sales £7.6bn (+5% CER); Specialty Medicines £3.2bn (+14%). Core operating profit +10%, Core EPS +9%. Strong cash generation; 17p Q1 dividend. 2026 guidance and >£40bn 2031 target reaffirmed.
29 April 2026
MAIRE Q1 2026: Revenues & EBITDA up; 2026 guidance confirmed
Q1: Net income €76.7m (+19.9%); adjusted net cash €396.1m; order intake €4.78bn; backlog €15.73bn; Nextchem revenue +46%; record dividend €0.585/share
29 April 2026
INEOS Acetyls and Sandpiper partner on 1.1 MTPA low‑carbon methanol plant in Texas City
FEED starts Q2 2026; FID targeted 2027; first production 2030. ~$1.7B capex. Up to 300,000 t/y to Acetic Acid. ~1,500 construction jobs, 25 permanent. CCS targets 97% capture.
← Previous
Next →
